Barclays
PKBO

Barclays’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Barclays’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,583
Closed -$212K – 5426
2022
Q1 		$212K Buy
+21,583
New +$212K ﹤0.01% 3389

Other funds holding PKBO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Barclays's PKBO Position: Q2 2022 in Review

Barclays sold out of Peak Bio, Inc. Common Stock (PKBO) in Q2 2022, closing a stake of 21,583 shares — an estimated $212K sold.

Barclays first reported a position in PKBO in Q1 2022 and held it in 1 quarter. The position peaked at $212K in Q1 2022. 42 funds tracked by Wall St. Rank hold PKBO as of Q2 2022.

  • Barclays reported no remaining Peak Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 21,583 Peak Bio, Inc. Common Stock shares in Q2 2022, an estimated $212K.
  • Barclays first reported a position in Peak Bio, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Barclays's Peak Bio, Inc. Common Stock position peaked at $212K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.